168 related articles for article (PubMed ID: 19180802)
1. Anti-immunoglobulin responses to IgG, F(ab')2, and Fab botulinum antitoxins in mice.
Mayers CN; Veall S; Bedford RJ; Holley JL
Immunopharmacol Immunotoxicol; 2003 Aug; 25(3):397-408. PubMed ID: 19180802
[TBL] [Abstract][Full Text] [Related]
2. Botulinum type A toxin neutralisation by specific IgG and its fragments: a comparison of mouse systemic toxicity and local flaccid paralysis assays.
Jones RG; Alsop TA; Hull R; Tierney R; Rigsby P; Holley J; Sesardic D
Toxicon; 2006 Sep; 48(3):246-54. PubMed ID: 16870221
[TBL] [Abstract][Full Text] [Related]
3. Biodistribution of monoclonal IgG1, F(ab')2, and Fab' in mice after intravenous injection. Comparison between anti-B cell (anti-Lyb8.2) and irrelevant (MOPC-21) antibodies.
Holton OD; Black CD; Parker RJ; Covell DG; Barbet J; Sieber SM; Talley MJ; Weinstein JN
J Immunol; 1987 Nov; 139(9):3041-9. PubMed ID: 3499463
[TBL] [Abstract][Full Text] [Related]
4. Initial recovery and rebound of type f intestinal colonization botulism after administration of investigational heptavalent botulinum antitoxin.
Fagan RP; Neil KP; Sasich R; Luquez C; Asaad H; Maslanka S; Khalil W
Clin Infect Dis; 2011 Nov; 53(9):e125-8. PubMed ID: 21896700
[TBL] [Abstract][Full Text] [Related]
5. Development and evaluation of candidate vaccine and antitoxin against botulinum neurotoxin serotype F.
Yu YZ; Zhang SM; Ma Y; Zhu HQ; Wang WB; Du Y; Zhou XW; Wang RL; Wang S; Yu WY; Huang PT; Sun ZW
Clin Immunol; 2010 Nov; 137(2):271-80. PubMed ID: 20696619
[TBL] [Abstract][Full Text] [Related]
6. Humoral anti-OV-TL 3 response after the intravenous administration of radiolabelled Fab' or F(ab')2 fragments in ovarian cancer patients.
Tibben JG; Thomas CM; Massuger LF; Segers MF; Schijf CP; Corstens FH; Boerman OC
Nucl Med Commun; 1995 Oct; 16(10):853-9. PubMed ID: 8570116
[TBL] [Abstract][Full Text] [Related]
7. Targeting human prostate cancer with 111In-labeled D2B IgG, F(ab')2 and Fab fragments in nude mice with PSMA-expressing xenografts.
Lütje S; van Rij CM; Franssen GM; Fracasso G; Helfrich W; Eek A; Oyen WJ; Colombatti M; Boerman OC
Contrast Media Mol Imaging; 2015; 10(1):28-36. PubMed ID: 24764162
[TBL] [Abstract][Full Text] [Related]
8. Development and preclinical evaluation of a new F(ab')₂ antitoxin against botulinum neurotoxin serotype A.
Yu YZ; Zhang SM; Wang WB; Du Y; Zhu HQ; Wang RL; Zhou XW; Lin JB; Wang S; Yu WY; Huang PT; Sun ZW
Biochimie; 2010 Oct; 92(10):1315-20. PubMed ID: 20600570
[TBL] [Abstract][Full Text] [Related]
9. Pre-existing canine anti-IgG antibodies: implications for immunotherapy, immunogenicity testing and immunoassay analysis.
Bergman D; Bäckström C; Hansson-Hamlin H; Larsson A; Holst BS
Sci Rep; 2020 Jul; 10(1):12696. PubMed ID: 32728049
[TBL] [Abstract][Full Text] [Related]
10. A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo.
Brezski RJ; Kinder M; Grugan KD; Soring KL; Carton J; Greenplate AR; Petley T; Capaldi D; Brosnan K; Emmell E; Watson S; Jordan RE
MAbs; 2014; 6(5):1265-73. PubMed ID: 25517311
[TBL] [Abstract][Full Text] [Related]
11. Production of anti-horse antibodies induced by IgG, F(ab')2 and Fab applied repeatedly to rabbits. Effect on antivenom pharmacokinetics.
Vázquez H; Olvera F; Alagón A; Sevcik C
Toxicon; 2013 Dec; 76():362-9. PubMed ID: 24047962
[TBL] [Abstract][Full Text] [Related]
12. Radiolabeled monoclonal antibody 15 and its fragments for localization and imaging of xenografts of human lung cancer.
Endo K; Kamma H; Ogata T
J Natl Cancer Inst; 1988 Aug; 80(11):835-42. PubMed ID: 3392743
[TBL] [Abstract][Full Text] [Related]
13. Preparation and performance of bispecific F(ab' gamma)2 antibody containing thioether-linked Fab' gamma fragments.
Glennie MJ; McBride HM; Worth AT; Stevenson GT
J Immunol; 1987 Oct; 139(7):2367-75. PubMed ID: 2958547
[TBL] [Abstract][Full Text] [Related]
14. The binding parameters of radiolabelled monoclonal F (ab')2 and Fab' fragments relative to immunoglobulin G in reactions with surface-bound antigens.
Fjeld JG; Michaelsen TE; Nustad K
Eur J Nucl Med; 1992; 19(6):402-8. PubMed ID: 1618231
[TBL] [Abstract][Full Text] [Related]
15. Role of Homologous Fc Fragment in the Potency and Efficacy of Anti-Botulinum Antibody Preparations.
Torgeman A; Ozeri E; Ben David A; Diamant E; Rosen O; Schwartz A; Barnea A; Makovitzki A; Mimran A; Zichel R
Toxins (Basel); 2017 May; 9(6):. PubMed ID: 28555060
[TBL] [Abstract][Full Text] [Related]
16. Parallelism of serum anti-F(ab')2 and anti-cationic IgG reactivities in patients with systemic lupus erythematosus.
Silvestris F; Yancey WB; Malone C; Searles R; Dammacco F; Williams RC
Clin Immunol Immunopathol; 1991 May; 59(2):256-70. PubMed ID: 2009644
[TBL] [Abstract][Full Text] [Related]
17. IgM and IgG anti-F(ab')2 antibodies in rheumatoid arthritis and systemic lupus erythematosus.
Heimer R; Wolfe LD; Abruzzo JL
Arthritis Rheum; 1982 Nov; 25(11):1298-1306. PubMed ID: 6982718
[TBL] [Abstract][Full Text] [Related]
18. Comparison between IgG and F(ab')(2) polyvalent antivenoms: neutralization of systemic effects induced by Bothrops asper venom in mice, extravasation to muscle tissue, and potential for induction of adverse reactions.
León G; Monge M; Rojas E; Lomonte B; Gutiérrez JM
Toxicon; 2001 Jun; 39(6):793-801. PubMed ID: 11137538
[TBL] [Abstract][Full Text] [Related]
19. Activation and proliferation signals in mouse B cells. V.A. comparison of the effects of intact (IgG) and F (ab')2 anti-mu or anti-delta antibodies.
Klaus GG; Bijsterbosch MK; Parkhouse RM
Immunology; 1985 Apr; 54(4):677-83. PubMed ID: 2984110
[TBL] [Abstract][Full Text] [Related]
20. Single-reagent one-step procedures for the purification of ovine IgG, F(ab')2 and Fab antivenoms by caprylic acid.
Al-Abdulla I; Casewell NR; Landon J
J Immunol Methods; 2014 Jan; 402(1-2):15-22. PubMed ID: 24246428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
